5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases

Lancet. 1966 Nov 12;2(7472):1049-52. doi: 10.1016/s0140-6736(66)92028-9.
No abstract available

MeSH terms

  • Alcoholism / drug therapy
  • Bipolar Disorder / cerebrospinal fluid
  • Central Nervous System Diseases / cerebrospinal fluid*
  • Humans
  • Hydroxyindoleacetic Acid / cerebrospinal fluid*
  • Imipramine / therapeutic use
  • Mental Disorders / cerebrospinal fluid*
  • Schizophrenia / cerebrospinal fluid

Substances

  • Hydroxyindoleacetic Acid
  • Imipramine